Jon Marc Wigginton - Jan 30, 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Director
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Stock symbol
CMPI
Transactions as of
Jan 30, 2022
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 03:25 PM
Previous filing
Jun 7, 2021
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +20.1K $0.00 20.1K Jan 30, 2022 Common Stock 20.1K $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 1/3 on the first anniversary of the grant date and monthly thereafter through the third anniversary of the grant date, subject to the Reporting Persons continued service through such date.